These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 20036137

  • 1. Editorial comment: mediastinal restaging: has the Holy Grail been found?
    Van Schil PE, Hendriks JM, De Waele M, Lauwers P.
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):780-1. PubMed ID: 20036137
    [No Abstract] [Full Text] [Related]

  • 2. Non-small-cell lung cancer restaging with transcervical extended mediastinal lymphadenectomy.
    Zieliński M, Hauer L, Hauer J, Nabiałek T, Szlubowski A, Pankowski J.
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):776-80. PubMed ID: 20044265
    [Abstract] [Full Text] [Related]

  • 3. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F, De Pas T, Catalano G, Piperno G, Curigliano G, Solli P, Veronesi G, Petrella F, Spaggiari L.
    J Natl Cancer Inst; 2007 Aug 01; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract] [Full Text] [Related]

  • 4. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
    Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y.
    Eur J Cardiothorac Surg; 2008 Jul 01; 34(1):187-95. PubMed ID: 18457958
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of lymph node metastasis in the contralateral mediastinum or scalene through mediastinoscopy and para-mediastinal small incision in potentially operable non-small cell lung cancer].
    Zhang SY, Wang X, Rong TH, Zheng L, Zeng CG, Xie ZM, Yu H, Zhu ZH.
    Zhonghua Zhong Liu Za Zhi; 2007 Aug 01; 29(8):629-31. PubMed ID: 18210888
    [Abstract] [Full Text] [Related]

  • 6. Induction therapy in non-small-cell lung cancer: a comparison of clinical and post-surgical staging.
    Granone PL, Margaritora S, Cesario A, Galetta D.
    Ann Ital Chir; 1999 Aug 01; 70(6):899-903. PubMed ID: 10804669
    [Abstract] [Full Text] [Related]

  • 7. Is radical mediastinal dissection mandatory for curative resection of NSCLC?
    Belcher E, Goldstraw P.
    Eur J Cardiothorac Surg; 2007 Jan 01; 31(1):142-3; author reply 143-4. PubMed ID: 17092737
    [No Abstract] [Full Text] [Related]

  • 8. Optimal management of patients with non-small cell lung cancer with ipsilateral mediastinal lymph node metastases.
    Battafarano RJ.
    J Thorac Cardiovasc Surg; 2006 Jun 01; 131(6):1227-8. PubMed ID: 16733149
    [No Abstract] [Full Text] [Related]

  • 9. Surgical treatment of non-small cell lung cancer: mediastinal lymph node dissection.
    Meacci E, Margaritora S, Cesario A, Porziella V, Kawamukai K, Piraino A, Vita ML, Tessitore A, Cusumano G, Granone P.
    Rays; 2004 Jun 01; 29(4):423-9. PubMed ID: 15852730
    [Abstract] [Full Text] [Related]

  • 10. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a closer look at redo mediastinoscopy.
    Granone P, Van Schil P, Cesario A.
    J Thorac Cardiovasc Surg; 2007 Jan 01; 133(1):275-6; author reply 276-7. PubMed ID: 17198837
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.
    Ann Thorac Surg; 2006 Jan 01; 81(1):292-7. PubMed ID: 16368383
    [Abstract] [Full Text] [Related]

  • 12. Mediastinal staging of non-small-cell lung cancer.
    Dhillon SS, Dhillon JK, Yendamuri S.
    Expert Rev Respir Med; 2011 Dec 01; 5(6):835-50; quiz 851. PubMed ID: 22082168
    [Abstract] [Full Text] [Related]

  • 13. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
    Magnanelli G, Scanagatta P, Benato C, Terzi A, Lonardoni A, Falezza G, Furlan G, Calabrò F.
    Chir Ital; 2006 Dec 01; 58(1):19-22. PubMed ID: 16729605
    [Abstract] [Full Text] [Related]

  • 14. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP.
    Eur J Surg Oncol; 2006 Jun 01; 32(5):583-7. PubMed ID: 16621424
    [Abstract] [Full Text] [Related]

  • 15. Is VAMLA/TEMLA the new standard of preresection staging of non-small cell lung cancer?
    Yendamuri S, Demmy TL.
    J Thorac Cardiovasc Surg; 2012 Sep 01; 144(3):S14-7. PubMed ID: 22503199
    [Abstract] [Full Text] [Related]

  • 16. Restaging after neo-adjuvant chemoradiotherapy for N2 non-small cell lung cancer.
    Cerfolio RJ, Bryant AS.
    Thorac Surg Clin; 2008 Nov 01; 18(4):417-21, vii. PubMed ID: 19086610
    [Abstract] [Full Text] [Related]

  • 17. Does systematic mediastinal lymphadenectomy contribute to better prognosis? An argument about Izbicki's article.
    Ogawa J.
    Ann Thorac Cardiovasc Surg; 1998 Dec 01; 4(6):301-2. PubMed ID: 9988579
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transcervical extended mediastinal lymphadenectomy--the new operative technique and early results in lung cancer staging.
    Kuzdzał J, Zieliński M, Papla B, Szlubowski A, Hauer Ł, Nabiałek T, Sośnicki W, Pankowski J.
    Eur J Cardiothorac Surg; 2005 Mar 01; 27(3):384-90; discussion 390. PubMed ID: 15740943
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.